Tuesday , October 24 2017
Home / Health / Sanofi, Novo Nordisk and Lilly named in sufferers’ price fixing suit

Sanofi, Novo Nordisk and Lilly named in sufferers’ price fixing suit


NEW YORK (Reuters) – Three of the most important makers of diabetes remedies, Sanofi SA <SASY.PA>, Novo Nordisk <NOVOb.CO> and Eli Lilly & Co <LLY.N>, have been named in a category motion lawsuit about price fixing filed by a gaggle of sufferers.

The suit, filed in a federal courtroom in Massachusetts, says that the businesses in the course of the previous 5 years have concurrently hiked the price of insulin by over 150 %.

(Reporting by Caroline Humer; Editing by Sandra Maler)


Source link

Check Also

What do you need to know about a polypectomy?

We look the polypectomy process, together with the varied surgical choices, surgical dangers and restoration …

Leave a Reply

Your email address will not be published. Required fields are marked *

*